Protective function of pyridoxamine on retinal photoreceptor cells via activation of the p-Erk1/2/Nrf2/Trx/ASK1 signalling pathway in diabetic mice

被引:16
作者
Ren, Xiang [1 ]
Sun, Hong [1 ,2 ]
Zhang, Chenghong [1 ]
Li, Chen [1 ,3 ]
Wang, Jinlei [1 ,2 ]
Shen, Jie [1 ,2 ]
Yu, Dong [1 ,2 ]
Kong, Li [1 ]
机构
[1] Dalian Med Univ, Dept Histol & Embryol, 9 Lvshun South Rd, Dalian 116044, Liaoning, Peoples R China
[2] Dalian Med Univ, Year Program Clin Med 7, Coll Basic Med, Dalian 116044, Liaoning, Peoples R China
[3] Zhuzhou Kaide Cardiovasc Dis Hosp, Dept Internal Med, Zhuzhou 412000, Hunan, Peoples R China
关键词
diabetic retinopathy; pyridoxamine; thioredoxin; apoptosis; GENE-EXPRESSION; RETINOPATHY; PHASE-2;
D O I
10.3892/mmr.2016.5270
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study aimed to investigate the mechanisms that mediate the protective effects of pyridoxamine (PM) on light-damaged retinal photoreceptor cells in diabetic mice. A high-fat diet and streptozotocin were used to induce a mouse model of type II diabetes. During the experiment, mice were divided the mice into three types of group, as follows: Control groups (negative control and light-damaged groups); experimental groups (diabetic and diabetic light-damaged groups); and treatment groups (25, 50 and 100 mg/kg PM-treated groups). Using hematoxylin-eosin staining, the number of nuclear layer cells were counted. Western blotting and immunohistochemistry were performed to measure the levels of thioredoxin (Trx), phospho-extracellular signal-regulated kinase 1/2 (p-Erk1/2), nuclear factor erythroid 2-related factor 2 (Nrf2) and apoptosis signal-regulating kinase 1 (ASK1). The photoreceptor cell count in the outer nuclear layer of the light-damaged, diabetic control and diabetic light-damaged groups were significantly reduced compared with the negative control group (P<0.001). The cell counts in the PM-treated groups were significantly increased compared with the diabetic group (P<0.001). Compared with the negative control group, the light-damaged, diabetic and diabetic light-damaged groups exhibited significantly decreased Trx, p-Erk1/2 and Nrf2 expression levels (P<0.001), and significantly increased ASK1 expression levels (P<0.001). However, in the PM-treated groups, Trx, p-Erk1/2 and Nrf2 expression levels were significantly increased (P<0.001), and ASK1 expression was significantly decreased (P<0.001). The results of the present study demonstrate that PM protects retinal photoreceptor cells against light damage in diabetic mice, and that its mechanism may be associated with the upregulation of Trx, p-Erk1/2 and Nrf2 expression, and the downregulation of ASK1 expression.
引用
收藏
页码:420 / 424
页数:5
相关论文
共 17 条
[1]   The pathobiology of diabetic complications - A unifying mechanism [J].
Brownlee, M .
DIABETES, 2005, 54 (06) :1615-1625
[2]   Pyridoxine and pyridoxamine inhibits superoxide radicals and prevents lipid peroxidation, protein glycosylation, and (Na++K+)-ATPase activity reduction in high glucose-treated human erythrocytes [J].
Jain, SK ;
Lim, G .
FREE RADICAL BIOLOGY AND MEDICINE, 2001, 30 (03) :232-237
[3]   The Flavonoid, Eriodictyol, Induces Long-term Protection in ARPE-19 Cells through Its Effects on Nrf2 Activation and Phase 2 Gene Expression [J].
Johnson, Jennifer ;
Maher, Pamela ;
Hanneken, Anne .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2009, 50 (05) :2398-2406
[4]  
LAURENT TC, 1964, J BIOL CHEM, V239, P3436
[5]   Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method [J].
Livak, KJ ;
Schmittgen, TD .
METHODS, 2001, 25 (04) :402-408
[6]   Vitamin supplementation reduces the progression of atherosclerosis in hyperhomocysteinemic renal-transplant recipients [J].
Marcucci, R ;
Zanazzi, M ;
Bertoni, E ;
Rosati, A ;
Fedi, S ;
Lenti, M ;
Prisco, D ;
Castellani, S ;
Abbate, R ;
Salvadori, M .
TRANSPLANTATION, 2003, 75 (09) :1551-1555
[7]  
Organisciak DT, 1998, INVEST OPHTH VIS SCI, V39, P1107
[8]   Differential regulation and properties of MAPKs [J].
Raman, M. ;
Chen, W. ;
Cobb, M. H. .
ONCOGENE, 2007, 26 (22) :3100-3112
[9]   Prevalence of diabetic retinopathy in Type2 diabetes in developing and developed countries [J].
Ruta, L. M. ;
Magliano, D. J. ;
LeMesurier, R. ;
Taylor, H. R. ;
Zimmet, P. Z. ;
Shaw, J. E. .
DIABETIC MEDICINE, 2013, 30 (04) :387-398
[10]  
Seger R, 1995, ENDOCRINOLOGY, V9, P726